Financials

News Ideas Discussions Technicals Forecast Seasonals

SLNCF fundamentals

An in-depth look to Silence Therapeutics, Plc. operating, investing, and financing activities

SLNCF free cash flow for Q2 25 is -22.73 M USD. For 2024, SLNCF free cash flow was -66.43 M USD and operating cash flow was -66.23 M USD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q1 '25

Q2 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q1 '25

Q2 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—